Abstract
We describe 6 clinical isolates of Elizabethkingia anophelis from a pediatric referral hospital in Cambodia, along with 1 isolate reported from Thailand. Improving diagnostic microbiological methods in resource-limited settings will increase the frequency of reporting for this pathogen. Consensus on therapeutic options is needed, especially for resource-limited settings.
Keywords:
Cambodia; Elizabethkingia anophelis; Laos; Thailand; antimicrobial resistance; bacteria; neonatal sepsis.
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Anti-Bacterial Agents / therapeutic use
-
Bacteremia / diagnosis*
-
Bacteremia / drug therapy
-
Ciprofloxacin / pharmacology
-
Ciprofloxacin / therapeutic use
-
Female
-
Flavobacteriaceae / drug effects
-
Flavobacteriaceae / genetics
-
Flavobacteriaceae / isolation & purification*
-
Flavobacteriaceae Infections / diagnosis*
-
Flavobacteriaceae Infections / drug therapy
-
Humans
-
Infant, Newborn
-
Microbial Sensitivity Tests
-
Vancomycin / pharmacology
-
Vancomycin / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Ciprofloxacin
-
Vancomycin
Supplementary concepts
-
Elizabethkingia anophelis